Cas no 85264-33-1 ((3,5-Dimethyl-1H-pyrazol-1-yl)methanol)
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Chemical and Physical Properties
Names and Identifiers
-
- (3,5-Dimethyl-1H-pyrazol-1-yl)methanol
- 3,5-Dimethyl-1-hydroxymethylpyrazole
- 3,5-Dimethyl-1H-pyrazole-1-methanol
- (3,5-dimethylpyrazol-1-yl)methanol
- 3,5-DIMETHYLPYRAZOLE-1-METHANOL
- 1-(2-hydroxymethyl)-3,5-dimethylpyrazole
- 1-(hydroxymethyl)-3,5-dimethyl-1H-pyrazole
- 1H-Pyrazole-1-methanol,3,5-dimethyl
- 1-hydroxymethyl-3,5-dimethylpyrazole
- 3,5-Dimethyl pyrazole-1-carbinol
- Dimethyl hydroxymethyl pyrazole
- EINECS 286-553-0
- 1H-Pyrazole-1-methanol, 3,5-dimethyl-
- 3,5-dimethylpyrazol-1-methanol
- 3,5-Dimethylpyrazole-1-carbinol
- OBENDWOJIFFDLZ-UHFFFAOYSA-N
- 968267D0AP
- (3,5-dimethyl-pyrazol-1-yl)-methanol
- 1-(hydroxymethyl)-3,5-dimethylpyr
- 3,5-Dimethyl-1H-pyrazole-1-methanol (ACI)
- Pyrazole-1-methanol, 3,5-dimethyl- (7CI)
- 1-(Hydroxymethyl)-3,5-dimethylpyrazole
- 2-(Hydroxymethyl)-3,5-dimethylpyrazole
- 3,5-Dimethyl-1-(hydroxymethyl)pyrazole
- Di(3,5-dimethyl-1H-pyrazol-1-yl)-1-methanol
- N-(Hydroxymethyl)-3,5-dimethylpyrazole
- NSC 71880
-
- MDL: MFCD00020738
- Inchi: 1S/C6H10N2O/c1-5-3-6(2)8(4-9)7-5/h3,9H,4H2,1-2H3
- InChI Key: OBENDWOJIFFDLZ-UHFFFAOYSA-N
- SMILES: OCN1C(C)=CC(C)=N1
- BRN: 115623
Computed Properties
- Exact Mass: 126.07900
- Monoisotopic Mass: 126.079
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 9
- Rotatable Bond Count: 1
- Complexity: 97.1
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.4
- Topological Polar Surface Area: 38
- Surface Charge: 0
- Tautomer Count: nothing
Experimental Properties
- Color/Form: Not determined
- Density: 1.1192 (rough estimate)
- Melting Point: 108.0 to 112.0 deg-C
- Boiling Point: 234.28°C (rough estimate)
- Flash Point: 87.3°C
- Refractive Index: 1.5010 (estimate)
- PSA: 38.05000
- LogP: 0.44970
- Solubility: Not determined
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Security Information
-
Symbol:
- Prompt:warning
- Signal Word:Warning
- Hazard Statement: H315-H319
- Warning Statement: P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38-52/53
- Safety Instruction: S26-S37/39
- RTECS:UQ7159000
-
Hazardous Material Identification:
- Risk Phrases:R36/37/38
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Customs Data
- HS CODE:2933199090
- Customs Data:
China Customs Code:
2933199090Overview:
2933199090. Other structurally non fused pyrazole ring compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM188966-500g |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 98% | 500g |
$499 | 2021-08-05 | |
| TRC | B429878-250mg |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 250mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B429878-500mg |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 500mg |
$ 65.00 | 2022-06-07 | ||
| TRC | B429878-2.5g |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 2.5g |
$ 80.00 | 2022-06-07 | ||
| Apollo Scientific | OR28784-5g |
3,5-Dimethyl-1-(hydroxymethyl)-1H-pyrazole |
85264-33-1 | 5g |
£18.00 | 2025-02-19 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | SA01891-25g |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 99% | 25g |
¥1188.0 | 2024-07-19 | |
| abcr | AB112964-25 g |
3,5-Dimethyl-1H-pyrazole-1-methanol, 98+%; . |
85264-33-1 | 25g |
€114.60 | 2023-01-31 | ||
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | D2199-25G |
3,5-Dimethyl-1-hydroxymethylpyrazole |
85264-33-1 | >98.0%(T) | 25g |
¥440.00 | 2024-04-15 | |
| Chemenu | CM188966-100g |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 98% | 100g |
$204 | 2023-02-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | D154762-100g |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol |
85264-33-1 | 98% | 100g |
¥1269.90 | 2023-09-03 |
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Production Method
Production Method 1
Production Method 2
Production Method 3
Production Method 4
Production Method 5
Production Method 6
Production Method 7
Production Method 8
Production Method 9
Production Method 10
Production Method 11
Production Method 12
Production Method 13
Production Method 14
Production Method 15
Production Method 16
Production Method 17
Production Method 18
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Raw materials
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Preparation Products
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Suppliers
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol Related Literature
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
Additional information on (3,5-Dimethyl-1H-pyrazol-1-yl)methanol
Introduction to (3,5-Dimethyl-1H-pyrazol-1-yl)methanol and Its Significance in Modern Chemical Research
(3,5-Dimethyl-1H-pyrazol-1-yl)methanol, with the CAS number 85264-33-1, is a versatile heterocyclic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its pyrazole core substituted with methyl groups at the 3 and 5 positions, exhibits unique structural and functional properties that make it a valuable scaffold for the development of novel therapeutic agents.
The pyrazole moiety is a six-membered aromatic ring containing two nitrogen atoms at the 1 and 4 positions. This structural feature imparts significant chemical diversity and reactivity, making pyrazole derivatives ideal candidates for drug discovery. In particular, (3,5-Dimethyl-1H-pyrazol-1-yl)methanol has been explored for its potential applications in various biological pathways, including enzyme inhibition and receptor binding.
Recent studies have highlighted the importance of (3,5-Dimethyl-1H-pyrazol-1-yl)methanol in the development of small-molecule inhibitors targeting critical biological processes. For instance, researchers have demonstrated its efficacy in modulating kinases, which are enzymes involved in cell signaling pathways. The methanol substituent at the 1-position of the pyrazole ring provides a hydroxyl group that can engage in hydrogen bonding interactions, enhancing binding affinity to target proteins.
One of the most compelling aspects of (3,5-Dimethyl-1H-pyrazol-1-yl)methanol is its ability to serve as a building block for more complex molecules. By incorporating this scaffold into larger structures, chemists can fine-tune pharmacological properties such as solubility, bioavailability, and metabolic stability. This flexibility has led to its use in designing compounds with potential therapeutic applications in areas such as oncology, inflammation, and neurodegenerative diseases.
The synthesis of (3,5-Dimethyl-1H-pyrazol-1-yl)methanol typically involves multi-step organic reactions that highlight the compound's synthetic accessibility. Advanced synthetic methodologies have been developed to improve yields and purity, enabling researchers to explore its full potential. These methods often include cyclization reactions, alkylation processes, and functional group transformations that are well-established in organic chemistry.
In the realm of drug discovery, the exploration of natural product-inspired scaffolds has been particularly fruitful. Compounds derived from natural sources often exhibit unique biological activities due to their complex structures. (3,5-Dimethyl-1H-pyrazol-1-yl)methanol, while not directly derived from a natural product, shares structural similarities with certain bioactive molecules found in nature. This has prompted researchers to investigate its derivatives as potential leads for new drugs.
The pharmacokinetic properties of (3,5-Dimethyl-1H-pyrazol-1-yl)methanol are also of great interest. Studies have shown that modifications to the pyrazole ring can significantly impact how a compound is absorbed, distributed, metabolized, and excreted by the body. Understanding these properties is crucial for optimizing drug candidates for clinical use. The hydroxymethyl group in particular plays a role in determining metabolic pathways and interactions with biological systems.
Computational chemistry has played an increasingly important role in the study of (3,5-Dimethyl-1H-pyrazol-1-yl)methanol. Advanced computational methods allow researchers to predict molecular interactions and optimize lead compounds before experimental synthesis. This approach not only saves time but also reduces costs associated with traditional trial-and-error drug discovery methods.
The future prospects for (3,5-Dimethyl-1H-pyrazol-1-yl)methanol are vast. As our understanding of biological systems continues to grow, so does the demand for innovative therapeutic agents. This compound remains a promising candidate for further research due to its unique structural features and potential applications in various disease areas.
In conclusion, (3,5-Dimethyl-1H-pyrazol-1-yl)methanol, CAS number 85264-33-1, represents an exciting area of research within chemical biology and pharmaceutical science. Its versatile structure and functional properties make it a valuable tool for developing new drugs targeting critical biological pathways. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in future medical advancements.
85264-33-1 ((3,5-Dimethyl-1H-pyrazol-1-yl)methanol) Related Products
- 1072-91-9(1,3,5-Trimethylpyrazole)
- 98816-32-1(1H-Pyrazole-1-methanol,3-methyl-)
- 709674-66-8(1H-Pyrazole-1-methanol,3-ethyl-5-(1-methylethyl)-(9CI))
- 139649-54-0(1H-Pyrazole-1-methanol, 4-iodo-3,5-dimethyl-)
- 119789-95-6(1H-Pyrazole-1-methanol, 3,5-dimethyl-, monohydrochloride)
- 139755-58-1(1H-Pyrazole-1-methanol, 4-fluoro-3,5-dimethyl-)
- 492998-68-2(1H-Pyrazole-1-carboxylicacid,3,5-dimethyl-(9CI))
- 94230-83-8((4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methanol)
- 122606-07-9(1H-Pyrazole,1-(ethoxymethyl)-3,5-dimethyl-)
- 51355-78-3((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methanol)